Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications

Overview of attention for article published in Frontiers in Pharmacology, September 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,285 followers.

@DCharabaty @P_DeepakIBDMD @gilkaplan @IbdWustl @EdwardLoftus2 @ibddoctor @IBDMD @EdBarnesMD @IBDJournal @CrohnsColitisFn Also here, more worldwide comparisons https://t.co/HTPgB4AMcc

27 Apr 2019

Reply Repost Favourite

Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications https://t.co/wSfRWwYdZR

22 Sep 2018

Reply Repost Favourite

Availability & affordability of #drugs with a conditional approval by the #European #Medicine Agency; comparison of #Korea with other countries & the implications https://t.co/JyoD516JYK #pharmacology #pharmacy #healthcare #openaccess @SIPBS_Strath

10 Sep 2018

Reply Repost Favourite

Congratulations Brian on your newly published @FrontiersIn article: https://t.co/X8tITlmmLE

03 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.